26/08/2025
✨ SparkLabs 好消息 ✨很榮幸與大家分享，SparkLabs 投資組合中的兩家新創 MetAI 宇見智能 與 Health2Sync 智抗糖，雙雙入選《Forbes Asia 100 to Watch 2025》 名單。
• 𝗠𝗲𝘁𝗔𝗜（企業科技與機器人）：透過創新技術，將 2D 倉儲平面圖快速轉換為互動式 3D 環境，協助倉儲與晶片製造業者提升效率，並獲得國際與台灣產業領導者的支持。
• 𝗛𝗲𝗮𝗹𝘁𝗵𝟮𝗦𝘆𝗻𝗰（生技與醫療）：打造完整的數位健康管理平台，協助數百萬糖尿病患者更有效地管理病情，並能與醫師即時共享數據。
值得一提的是，今年名單中來自台灣的三家新創企業裡，有兩家來自 SparkLabs 投資組合。這不僅展現了團隊實力，也凸顯台灣在 AI、機器人與數位醫療創新領域日益增長的影響力。
在 SparkLabs Taiwan，我們的使命始終如一：支持早期 AI 新創走向國際，並推動全球科技與醫療的未來發展。
✨ 𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 SparkLabs Taiwan! ✨
We are proud to share that two SparkLabs portfolio companies, MetAI 宇見智能 and Health2Sync 智抗糖, have been recognized in the Forbes Asia 100 to Watch 2025 list.
• 𝗠𝗲𝘁𝗔𝗜 (Enterprise Technology & Robotics) is redefining logistics efficiency by converting 2D floor plans into interactive 3D environments, backed by global and Taiwanese industry leaders.
• 𝗛𝗲𝗮𝗹𝘁𝗵𝟮𝗦𝘆𝗻𝗰 (Biotechnology & Healthcare) is advancing digital health by enabling millions of diabetes patients to better manage their conditions and collaborate with their doctors.
Notably, two out of the three Taiwanese startups featured this year are SparkLabs portfolio companies. This recognition underscores not only the strength of these teams but also Taiwan’s growing influence in AI, robotics, and digital healthcare innovation.
At SparkLabs Taiwan, our mission remains clear: to empower early-stage AI startups to expand globally and contribute to shaping the future of technology and healthcare.
👉 Read the full list: Forbes Asia 100 to Watch 2025 (in comment)
